- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Frankfurt | 92,920 | 24.07.24 15:52:11 | +0,220 | +0,24% | 93,550 | 93,720 | 92,520 | 92,700 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 976,600 | 24.07.24 10:06:58 | -8,800 | -0,89% | 979,200 | 985,400 | 969,200 | 985,400 |
